Természetes hatóanyagok jelentőségének vizsgálata máj- és ...

101. Hunter, A.L., Neal, R.A.: Inhibition of hepatic mixed-function oxidase activity in
vitro and in vivo by various thiono-sulfur-containing compounds. Biochem Pharmacol.
1975, 24, 2199-2205.
102. Hurrell, R.F., Reddy, M., Cook, J.D.: Inhibition of non-haem iron absorption in man
by polyphenolic-containing beverages. Br. J. Nutr. 1999, 81, 289.
103. Huynh, H.T., Teel, R.W.: Effects of plant-derived phenols on rat liver cytochrome
P450 2B1 activity. Anticancer Res. 2002, 22, 1699-1703.
104. Jaeschke, H.: Reactive oxygen and mechanisms of inflammatory liver injury. J.
Gastroenterol. Hepatol. 2000, 15, 718-724.
105. Jantet, G.: Chronic venous insufficiency: worldwide results of the RELIEF study.
Reflux assessment and quality of life improvement with micronized flavonoids.
Angiology, 2002, 53, 245-256.
106. Johnson, I.T.: Anticarcinogenic effects of diet-related apoptosis in the colorectal
mucosa. Food Chem. Toxicol. 2002, 40, 1171-1178.
107. Justesen, U., Arrigoni, E., Larsen, B.R., Amadó, R.: Degradation of flavonoid
glycosides and aglycones during in vitro fermentation with human faecal flora.
Lebensmittel Wissenschaft und Technologie, 2000, 424-430.
108. Kabelitz, L.: Heavy metals in herbal drugs. Eur. J. Herb. Med. 1998, 4, 25-29.
109. Kahkonen, M.P., Heinonen, M.: Antioxidant activity of anthocyanins and their
aglycons. J Agric Food Chem., 2003, 51, 628 –633.
110. Kakumu, S., Murakami, H., Kuriki, J.: Activation of supressor function of human
peripheral blood T-cells by (+) cyanidanol-3: its application to chronic active liver
diseases. Clin. Exp. Immunol. 1983, 52, 430-436.
111. Kállai, L.: Laborállat-ismeretek. 4. Számok és törvények. Magyar Állatorvosok
Lapja 2001, 123, 173-179.
112. Kataba-Pendias, A., Pendias, H.: Trace elements in soils and plants. 3. ed., CRC
Press, Boca Raton, Florida
113. Kawaguchi, K., Mizuno, T., Aida K., Uchino, K.: Hesperidin as an inhibitor of
lipases from porcine pancreas and Pseudomonas. Biosci. Biotechnol. Biochem. 1997, 61,
102-104.
114. Keli, S.O., Hertog, M.G.L., Feskens, E.J.M., Kromhout, D.: Dietary flavonoids,
antioxidant vitamins and incidence of stroke: the Zutphen Elderly Study. Arch. Intern.
Med. 1996, 154, 637-642.
115. Khan, S., O’Brien, P.J.: Modulating hypoxia-induced hepatocyte injury by affecting
intracellular redox state. Biochem. Biophys. Acta 1995, 1269, 153-161.
116. Kim, H.K., Jeong, T.S., Lee, M. K., Park, Y.B., Choi, M.S.: Lipid-lowering efficacy
of hesperetin metabolites in high-cholesterol fed rats. Clin. Chim. Acta, 1999, 327, 129-
137.
117. Kocsis, I., Szentmihályi, K., Rapavi, E., Hubay, M., Kéry, A., Bányai, E., Szőke, E.,
Blázovics, A.: Effect of cichorium intybus (L.) extract on the redox balance and metal ion
content of fatty liver in hyperlipidemic rats. Trace Elem. Electro. 2004, 21, 262-268.
118. Kong, A.N., Yu, R., Chen, C., Mandlekar, S., Primiano, T.: Signal transduction
events elicited by natural products: role of MAPK and caspase pathways in homeostatic
response and induction of apoptosis. Arch. Pharm. Res., 2000, 23, 1-16.
119. Korthuis, R.I., Gute, D.C.: Postischemic leukocyta/endothelial cell interactions and
microvascular barrier disruption in skeletal muscle: cellular mechanism and effect of
Daflon 500 mg. Int. J. Microcirc. Clin. Exp. 1997, 17, 11-17.
120. Kurowska, E.M., Spence, J.D., Jordan, J.D., Wetmore, S., Freeman, D.J., Piche,
L.A., Serratore, P.: HDL-cholesterol-raising effect of orange juice in subjects with
hypercholesterolemia. Am. J. Clin. Nutr. 2000, 72, 1095-1100.
121. Labrid, C., Duhault, J., Vix, C.: Pharmacologic properties of Daflon 500 mg. Le
Journal International de Medicine. 1987, Suppl. au nº 85., 1-13.
137